TransMedics Group, Inc.

TMDX 10-K · FY 2025
API behind this page

TMDX FY 2025 request

Playground key active
Request URL /api/financials?ticker=TMDX&year=2025&quarter=4&full_year_mode=true
waiting 0 ms 
Pick an endpoint and run the request.
curl

Income Statement

JSON CSV Excel
Income Statement
Metric FY 2025 FY 2024 YoY
Revenue 605,494 441,540 +37.1%
Show Product Lines breakouts
Heart revenue [Member] · OCS transplant revenue [Member] 111,839 96,663 +15.7%
Heart revenue [Member] · OCS transplant revenue [Member] 14,169 13,198 +7.4%
Liver revenue [Member] · OCS transplant revenue [Member] 459,415 309,462 +48.5%
Liver revenue [Member] · OCS transplant revenue [Member] 1,113 158 +604.4%
Lung revenue [Member] · OCS transplant revenue [Member] 13,443 15,755 -14.7%
Lung revenue [Member] · OCS transplant revenue [Member] 1,418 1,926 -26.4%
Product 372,401 273,866 +36.0%
Service 233,093 167,674 +39.0%
Service Unrelated to OCS Transplant [Member] 4.1 4.4 -6.8%
Show Business Segments breakouts
OCS transplant revenue [Member] 601,397 437,162 +37.6%
OCS transplant revenue [Member] · All Other Countries [Member] 16,700 15,282 +9.3%
OCS transplant revenue [Member] · US 584,697 421,880 +38.6%
Cost of Revenue 242,688 179,459 +35.2%
Show Product Lines breakouts
Product 77,822 58,345 +33.4%
Service 164,866 121,114 +36.1%
Gross Profit 362,806 262,081 +38.4%
Research & Development 69,055 55,968 +23.4%
Show Income Statement Location breakouts
Clinical trials costs 1,459 478 +205.2%
Consulting and third-party services 15,492 12,920 +19.9%
Facility related and other 8,834 6,653 +32.8%
Laboratory supplies and research materials 17,550 13,990 +25.4%
Personnel related (including stock-based compensation expense) 25,720 21,927 +17.3%
Selling, General & Administrative 185,168 168,617 +9.8%
Show Income Statement Location breakouts
Facility related and other 33,584 24,212 +38.7%
NOP support 6,826 12,289 -44.5%
Personnel related (including stock-based compensation expense) 114,506 109,475 +4.6%
Professional and consultant fees 25,936 18,313 +41.6%
Tradeshows and conferences 4,316 4,328 -0.3%
Operating Expenses 254,223 224,585 +13.2%
Operating Income 108,583 37,496 +189.6%
Interest Expense -13,782 -14,409 +4.4%
Interest Income And Other Income Expense 12,721 12,693 +0.2%
Non-Operating Income (Expense) -1,061 -1,716 +38.2%
Income Before Taxes 107,522 35,780 +200.5%
Income Tax Expense (Benefit) 82,769 -316 +26292.7%
Net Income 190,291 35,464 +436.6%
Show Equity Components breakouts
Retained Earnings 190,291 35,464 +436.6%
EPS (Basic) 5.6 1.07 +423.4%
EPS (Diluted) 4.87 1.01 +382.2%
Wtd Avg Shares (Basic) 33,993,468 33,229,953 +2.3%
Wtd Avg Shares (Diluted) 40,540,694 35,216,837 +15.1%
Revenue (FY) — — —
Show Product Lines breakouts
Product 372,401 273,680 +36.1%
Comprehensive Income 190,779 35,299 +440.5%
Foreign Currency Transaction Gain Loss Before Tax (FY) — — —
Show Income Statement Location breakouts
Other Nonoperating Income Expense 1 -0.7 +242.9%

Balance Sheet

Balance Sheet
Metric FY 2025 FY 2024 YoY
Current Assets
Cash 488,366 336,650 +45.1%
Accounts Receivable 84,282 97,722 -13.8%
Inventory 48,881 46,554 +5.0%
Prepaid Expenses & Other Current Assets 16,254 16,290 -0.2%
Show Public Utilities Inventory breakouts
Spare Parts Inventory 4.7 4 +17.5%
Total Current Assets 637,783 497,216 +28.3%
Non-Current Assets
Property, Plant & Equipment 327,656 285,970 +14.6%
Operating Lease Right-of-Use Assets 5,155 6,481 -20.5%
Deferred Tax Assets 83,543 — —
Restricted Cash Noncurrent 500 500 0.0%
Goodwill 11,549 11,549 0.0%
Show Business Acquisition breakouts
Summit [Member] 11.5 11.5 0.0%
Other Non-Current Assets 239 208 +14.9%
Total Assets 1,068,373 804,076 +32.9%
Intangible Assets 1,948 2,152 -9.5%
Show Finite Lived Intangible Assets By Major Class breakouts
Customer Relationships 1,860 2,055 -9.5%
Other Intangible Assets 88 97 -9.3%
Other Assets
Intangible Assets Net Excluding Goodwill 1,948 2,152 -9.5%
Current Liabilities
Accounts Payable 10,350 10,292 +0.6%
Accrued Liabilities And Other Liabilities 62,740 45,152 +39.0%
Current Portion of Long-Term Debt 10,000 — —
Show Long-Term Debt Type breakouts
Term Loan [Member] 10,000 — —
Deferred Revenue (Current) 2,905 1,742 +66.8%
Operating Lease Liability Current 3,310 2,727 +21.4%
Total Current Liabilities 89,305 59,913 +49.1%
Non-Current Liabilities
Convertible Debt Noncurrent 452,804 449,939 +0.6%
Other Long Term Debt Noncurrent 49,587 59,372 -16.5%
Show Long-Term Debt Type breakouts
Term Loan [Member] 49,587 59,372 -16.5%
Operating Lease Liabilities 3,577 6,249 -42.8%
Total Liabilities 595,273 575,473 +3.4%
Other Liabilities
Operating Lease Liability 6,887 — —
Stockholders' Equity
Common Stock 750,926 697,208 +7.7%
Accumulated Other Comprehensive Income 124 -364 +134.1%
Retained Earnings -277,950 -468,241 +40.6%
Total Stockholders' Equity 473,100 228,603 +107.0%
Show Equity Components breakouts
Accumulated Other Comprehensive Income 124 -364 +134.1%
Common Stock 750,926 697,208 +7.7%
Retained Earnings -277,950 -468,241 +40.6%
Total Liabilities & Equity 1,068,373 804,076 +32.9%

Cash Flow Statement

Cash Flow Statement
Metric FY 2025 FY 2024 YoY
Operating Activities
Net Income 190,291 35,464 +436.6%
Depreciation & Amortization 27,185 19,758 +37.6%
Show Fair Value By Asset Class breakouts
Property Plant And Equipment 27 19.6 +37.8%
Stock-Based Compensation 36,861 33,224 +10.9%
Deferred Income Taxes -83,543 — —
Non Cash Interest And End Of Term Accretion Expense 3,080 3,111 -1.0%
Non Cash Lease Expense 2,132 1,564 +36.3%
Foreign Currency Transaction Gain Loss Unrealized -1,622 665 -343.9%
Gain Loss On Disposition Of Assets1 80 17 +370.6%
Change in Accounts Receivable 13,950 -34,310 +140.7%
Change in Inventory -7,716 -8,353 +7.6%
Change in Prepaid & Other Assets -3,759 -6,262 +40.0%
Increase Decrease In Other Noncurrent Assets -23 -149 +84.6%
Change in Accounts Payable -19 -1,396 +98.6%
Increase Decrease In Accrued Liabilities And Other Operating Liabilities 17,694 7,938 +122.9%
Change in Deferred Revenue 1,144 -203 +663.5%
Increase Decrease In Operating Lease Liability -2,895 -2,265 -27.8%
Net Cash from Operations 192,840 48,803 +295.1%
Investing Activities
Capital Expenditures -59,251 -129,744 +54.3%
Net Cash from Investing -59,251 -129,303 +54.2%
Inventory Transfer To Property Plant And Equipment 5,679 5,803 -2.1%
Right Of Use Asset Obtained In Exchange For Operating Lease Liability 795 1,499 -47.0%
Financing Activities
Proceeds From Stock Options Exercised 13,746 20,813 -34.0%
Proceeds From Stock Plans 3,249 2,061 +57.6%
Tax Withholding for Share Compensation -138 — —
Net Cash from Financing 16,857 22,874 -26.3%
Supplemental
Interest Paid 10,702 11,297 -5.3%
Unpaid Capital Expenditures 1,753 2,062 -15.0%
Income Taxes Paid 1,147 — —
Show Income Tax Authority breakouts
CA 802 — —
State And Local Tax Jurisdiction Other 145 — —
TX 200 — —
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 1,270 -536 +336.9%
Net Change in Cash 151,716 -58,162 +360.9%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 488,866 337,150 +45.0%
Restricted Cash 500 500 0.0%

Values in thousands USD. Source: SEC EDGAR 10-K filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key